Filing Details
- Accession Number:
- 0001181431-15-001001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-16 16:31:46
- Reporting Period:
- 2015-01-14
- Filing Date:
- 2015-01-16
- Accepted Time:
- 2015-01-16 16:31:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585666 | A. Allen Fienberg | C/O Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 | Vp Of Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-14 | 5,000 | $19.00 | 270,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 208,023 | Indirect | Held by J.D.F. Holdings Ltd. |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2014. The proceeds of this sale will be used primarily to cover the reporting person's tax liability arising from option exercises.
- Dr. Fienberg holds a 20% ownership interest in J.D.F. Holdings Ltd. and may be deemed to beneficially own the securities held by J.D.F. Holdings Ltd. Dr. Fienberg disclaims beneficial ownership of the securities held by J.D.F. Holdings Ltd. except to the extent of his pecuniary interest therein.